Literature DB >> 21422380

Angiotensin II binding to angiotensin I-converting enzyme triggers calcium signaling.

Paola B Guimarães1, Érika C Alvarenga, Paula D Siqueira, Edgar J Paredes-Gamero, Regiane A Sabatini, Rafael L T Morais, Rosana I Reis, Edson L Santos, Luis G D Teixeira, Dulce E Casarini, Renan P Martin, Suma I Shimuta, Adriana K Carmona, Clovis R Nakaie, Miriam G Jasiulionis, Alice T Ferreira, Jorge L Pesquero, Suzana M Oliveira, Michael Bader, Claudio M Costa-Neto, João B Pesquero.   

Abstract

Angiotensin (Ang) I-converting enzyme (ACE) is involved in the control of blood pressure by catalyzing the conversion of Ang I into the vasoconstrictor Ang II and degrading the vasodilator peptide bradykinin. Human ACE also functions as a signal transduction molecule, and the binding of ACE substrates or its inhibitors initiates a series of events. In this study, we examined whether Ang II could bind to ACE generating calcium signaling. Chinese hamster ovary cells transfected with an ACE expression vector reveal that Ang II is able to bind with high affinity to ACE in the absence of the Ang II type 1 and type 2 receptors and to activate intracellular signaling pathways, such as inositol 1,4,5-trisphosphate and calcium. These effects could be blocked by the ACE inhibitor, lisinopril. Calcium mobilization was specific for Ang II, because other ACE substrates or products, namely Ang 1-7, bradykinin, bradykinin 1-5, and N-acetyl-seryl-aspartyl-lysyl-proline, did not trigger this signaling pathway. Moreover, in Tm5, a mouse melanoma cell line endogenously expressing ACE but not Ang II type 1 or type 2 receptors, Ang II increased intracellular calcium and reactive oxygen species. In conclusion, we describe for the first time that Ang II can interact with ACE and evoke calcium and other signaling molecules in cells expressing only ACE. These findings uncover a new mechanism of Ang II action and have implications for the understanding of the renin-Ang system.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21422380     DOI: 10.1161/HYPERTENSIONAHA.110.167171

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  8 in total

1.  Sensitization of slow pressor angiotensin II (Ang II)-initiated hypertension: induction of sensitization by prior Ang II treatment.

Authors:  Baojian Xue; Zhongming Zhang; Ralph F Johnson; Alan Kim Johnson
Journal:  Hypertension       Date:  2012-01-03       Impact factor: 10.190

Review 2.  A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme.

Authors:  Kenneth E Bernstein; Frank S Ong; Wendell-Lamar B Blackwell; Kandarp H Shah; Jorge F Giani; Romer A Gonzalez-Villalobos; Xiao Z Shen; Sebastien Fuchs; Rhian M Touyz
Journal:  Pharmacol Rev       Date:  2012-12-20       Impact factor: 25.468

3.  Early pharmacological inhibition of angiotensin-I converting enzyme activity induces obesity in adulthood.

Authors:  Kely de Picoli Souza; Elton D da Silva; Elice C Batista; Felipe C G Reis; Sylvia M A Silva; Charlles H M Castro; Jaqueline Luz; Jorge L Pesquero; Edson L Dos Santos; João B Pesquero
Journal:  Front Pharmacol       Date:  2015-04-14       Impact factor: 5.810

4.  Angiotensin Converting Enzyme Regulates Cell Proliferation and Migration.

Authors:  Erika Costa de Alvarenga; Matheus de Castro Fonseca; Clarissa Coelho Carvalho; Rodrigo Machado Florentino; Andressa França; Eveline Matias; Paola Bianchi Guimarães; Carolina Batista; Valder Freire; Adriana Karaoglanovic Carmona; João Bosco Pesquero; Ana Maria de Paula; Giselle Foureaux; Maria de Fatima Leite
Journal:  PLoS One       Date:  2016-12-19       Impact factor: 3.240

Review 5.  The Coming of Age of the Angiotensin Hypothesis in Alzheimer's Disease: Progress Toward Disease Prevention and Treatment?

Authors:  Patrick Gavin Kehoe
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 6.  Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure.

Authors:  Lauren B Arendse; A H Jan Danser; Marko Poglitsch; Rhian M Touyz; John C Burnett; Catherine Llorens-Cortes; Mario R Ehlers; Edward D Sturrock
Journal:  Pharmacol Rev       Date:  2019-10       Impact factor: 25.468

Review 7.  Cardiovascular Drugs and Osteoarthritis: Effects of Targeting Ion Channels.

Authors:  Raminta Vaiciuleviciute; Daiva Bironaite; Ilona Uzieliene; Ali Mobasheri; Eiva Bernotiene
Journal:  Cells       Date:  2021-09-28       Impact factor: 6.600

8.  Tissue-specific expression of transgenic secreted ACE in vasculature can restore normal kidney functions, but not blood pressure, of Ace-/- mice.

Authors:  Saurabh Chattopadhyay; Sean P Kessler; Juliana Almada Colucci; Michifumi Yamashita; Preenie deS Senanayake; Ganes C Sen
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.